Interpreting the multi-biomarker disease activity score in the context of tocilizumab treatment for patients with rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1007/s00296-015-3285-2
Published Online: 2015-05-31
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Reiss, William G.
Devenport, Jenny N.
Low, Jason M.
Wu, George
Sasso, Eric H.
Text and Data Mining valid from 2015-05-31
Version of Record valid from 2015-05-31
Article History
Received: 2 February 2015
Accepted: 8 May 2015
First Online: 31 May 2015